Statistics for Cabozantinib for neurofibromatosis type 1-related plexiform neurofibromas: a phase 2 trial
Total visits
| views | |
|---|---|
| Cabozantinib for neurofibromatosis type 1-related plexiform neurofibromas: a phase 2 trial | 66 |
Total visits per month
| views | |
|---|---|
| May 2024 | 0 |
| June 2024 | 0 |
| July 2024 | 0 |
| August 2024 | 0 |
| September 2024 | 0 |
| October 2024 | 0 |
| November 2024 | 0 |
File Visits
| views | |
|---|---|
| nihms-1705876.pdf | 44 |
Top country views
| views | |
|---|---|
| United States | 51 |
| India | 2 |
| Canada | 1 |
| China | 1 |
| Germany | 1 |
| Italy | 1 |
| Malaysia | 1 |
| Netherlands | 1 |
Top city views
| views | |
|---|---|
| Wilmington | 41 |
| Ann Arbor | 2 |
| Cambridge | 2 |
| Delhi | 2 |
| Beijing | 1 |
| Gunzenhausen | 1 |
| Kansas City | 1 |
| Lake Mary | 1 |
| Las Vegas | 1 |
| Montreal | 1 |
| Orinda | 1 |
| Segrate | 1 |
| Seremban | 1 |
| Washington | 1 |